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tuberculosis and the costs of two alternative strategies for
managing the tuberculosis epidemic. We feel the costs
reported here are not excessive to prevent tuberculosis in
HIV-positive individuals, and to prevent its spread in the
community. ·In the evaluation of chemoprophylaxis policies,
however, other considerations must influence the decision.
These include the annual risk of developing tuberculosis,
patient compliance with the chemoprophylaxis programme,
the optimal period for administration of chemoprophylaxis,
levels of resistance to isoniazid and the duration of its
protective effect. By characterising 'the magnitude of the
resource costs of prevention compared with treatment of
active tuberculosis, we hope to open debate on these
equally important considerations.
Or Helen Schneider's substantial contribution to this paper is
gratefully acknowledged. Thanks are also due to Or Anne Mills
for comments on an earlier draft and Mrs Tanja Bruce for
assistance in the preparation of the manuscript.
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We examined the safety and utility of the combined
assessment of aspiration cytology and mammography in
705 women who had clinically suspicious or malignant
palpable breast masses. Histological assessment
confirmed 176 benign and 529 malignant lesions. There
were no incorrect (false positive) diagnoses made in the
176 benign masses when combined assessment was used
(specificity 1,0; predictive value 0,86); in isolation,
however, there was a false positive cytological diagnosis
('papillary carcinoma') and 3 false positive mammographic
diagnoses. Benign disease (false negative) was incorrectly
diagnosed by combined assessment in 4 of the 529
malignant masses (sensitiVity 0,99; predictive value 0,98):
cytological diagnoses were of fat necrosis (2) and benign
cells on cytospin (1) and aspiration biopsy (1);
mammographic diagnoses were of benign disease (2) and
normality (2). Indeterminate ('atypical', 'suspicious')
diagnoses were problematic and frequent (overall 223
(31,6%), malignant masses 137 (25,9%), benign masses 86
(48,9%); cytology 117 (16,6%), mammography 141 (20%).
Thus, with the combined assessment of mammography
and cytology in clinically suspicious breast masses, a
decisive diagnosis was made in about two-thirds of cases
allowing the safe commencement of therapy; the balance
of patients required core or excision biopsy.
S Atr Med J 1995; 85: 81-84.
Over the last two decades there has been a move away
from an initial histological assessment of suspicious breast
masses by open biopsy to their investigation by core biopsy,
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mammography and aspiration cytology. Numerous
publications report the sensitivity, specificity and predictive
values of these separate investigations, as well as those of
clinical evaluation, usually finding the values of each to be
high, but incomplete. In 1976 Kreuzer and Boquoi'
suggested that clinical examination, fine-needle aspiration
biopsy and mammography be combined as a triple
assessment, having found an error rate of less than 1% in
602 breast masses so evaluated. While some investigators
have found support for triple assessment;-6 and acted upon
it, others have found the mammographic component
unhelpful. 7.s A recent recommendation, however, was that
core or excision biopsy continue to be performed before
commencement of therapy, as cytological assessment was
insufficiently specific.9 We have examined the accuracy of
combined assessment in our practice.
Patients and methods
This study is a retrospective analysis of the results of
investigations performed on 705 women over 30 years of
age who presented to this unit between January 1984 and
March 1989. Each had a breast mass, which was
considered on clinical grounds to be malignant or suspicious
of malignancy and each underwent both fine-needle
aspiration biopsy and mammography. All had subsequent
histological diagnoses made by mastectomy, local excision
or Tru-Cut (Travenol) biopsy. Overall, 1 518 women with
malignant and 4 986 with benign disease were managed
during this period.
Clinical examination
All patients were examined by one of three surgical
consultants with a specific interest in breast disease before
investigations were performed, and the diagnosis of benign
or suspicious/malignant entered on a structured form. The
features that suggested malignancy were skin dimpling,
oedema, nipple retraction, Paget's disease, regional
adenopathy, hardness or shelving, or discrete masses in
those patients over the age of 30 years.
Fine-needle aspiration biopsy
The masses were aspirated with a 22-gauge needle, the
material smeared onto microscope slides and stained with a
modified Papanicolaou technique. The slides were
immediately examined by a cytotechnologist and, if acellular,
aspiration was repeated. The cytopathological diagnoses
were categorised as benign, indeterminate or malignant. The
indeterminate category included equivocal or atypical
lesions and those suspicious, but not diagnostic, of
malignancy.
Mammography
In the initial part of the study standard craniocaudal and
lateral views were taken with a Xerographic apparatus (Rank
Xerox); this was later replaced with a Senograph film-screen
system (CGR) Senographic, Paris). The results were reported
as normal, benign, equivocal or malignant; we have
combined the normal and benign diagnoses for convenience
of analysis.
All cytological and mammographic investigations that
produced reports discordant with the final histological
findings were reviewed. Any altered diagnoses were not
inclu'ded in the initial analysis but are presented with
possible reasons.
Results
On final histological examination 176 masses were found to
be benign and 529 masses malignant.
Benign masses (specificity of combined
assessment for malignancy)
The combined cytological and mammographic assessments
correctly identified 88 (50%) of 176 benign masses, and
were indeterminate or discordant in the remainder (Table I).
There were no false positive diagnoses when these'two
investigations were taken in conjunction, and no patit?nt had
unnecessary cancer surgery for benign disease. The:
absolute specificity was 0,5 and the relative predictive value
0,86 (Table 11). When cytological findings were analysed in
isolation, an incorrect diagnosis of malignancy was made in
1 (0,6%) patient (Case 1, Table 111): on cytological review the
features remain those of papillary carcinoma (malignant
papillary clusters), and inexplicably conflict with the benign
(reViewed) histological features. Also, in isolation, 3 (1,7%)
mammographic lesions were incorrectly identified as
malignant and the features remain suggestive of malignancy
on review.
Table I. The mammographic and cytological diagnoses in 176




Benign 88 32 2 122
Indeterminate 40 12 1 53
Malignant 0 1 0 1
- - - -
Total 128 45 3 176
Malignant mC!sses(sensitivity of
combined assessment for malignancy)
Combined assessment correctly identified 380 (71,8%) of
masses as malignant, made an indeterminate or discordant
diagnosis in 145 (27,4%), and missed malignancy in 4
(0,8%) patients (Table IV). The absolute sensitivity of
combined assessment was thus 0,72, and the predictive
value 0,96 (Table 11). In isolation, correct cytological
diagnoses were made in 455 (86%) cases, indeterminate
diagnoses in 64 (12,1 %); benign disease was incorrectly
diagnosed in 10 (1,9%) cases (Table 111): in 3 instances
degenerate cells were seen in cytospins from cysts (review
of the material remained unchanged in 2 patients, and
missed papillary groups were detected in the 3rd), fat
necrosis in 5 and benign cells in 3 instances (cytological
review found that in 2 instances the material had been
inadequate, and cells suspicious of carcinoma were found in
1). Correct mammographic diagnoses of malignancy were
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Table 11. Specificity, sensitivity and predictive values of cytological, mammographic and combined assessment
Sensitivity Predictive value
Benign Indeterminate Malignant Absolute Relative Absolute Relative
Malignant (529)
Cytology 10 64 455 0,86 0,98 0,92 0,7
Mammography 7 96 426 0,81 0,99 0,95 0,64
Combined 4 149 380 0,72 0,99 0,96 0,98
Benign (176)
Cytology 122 53 1 0,69 0,99 0,99 0,91
Mammography 128 45 3 0,73 0,98 0,99 0,92
Combined 88 88 ° 0,5 1 1 0,86Absolute calculations exclude.indeterminate values and relative calculations include them; diagnostic specificity and predictive value were calculated: true positive tests/true + false
positive tests; diagnostic sensitivity and predictive value were calculated: true negative tests/true negative + false negative tests.
Table Ill. The incorrect cytological and mammographic diagnoses with their reviewed and final histological diagnoses
Cytology Mammography
Case Age Final histology Clinical diagnosis Initial Reviewed Initial Reviewed
Benign masses
1. 83 Epithelial hyperplasia Malignant mass 2 cm Papillary carcinoma Ditto Suspicious opacity Ditto
2. 59 Granuloma Malignant mass 2 cm Inflammatory Ditto Malignant opacity Ditto
3. 70 Intraduct papilloma Malignant mass 2 cm Benign Ditto Malignant opacity Ditto
4. 75 Fibrous tissue Malignant mass 5 cm Benign Ditto Malignant stellate Ditto
lesion
Malignant masses
5. 50. Lobular & ductal Malignant mass 6 cm Benign cytospin Ditto Benign Suspicious
carcinoma in situ
6. 88 Carcinoma NOS Suspicious mass 3 cm Benign (macrophages) Ditto Benign Benign
7. 48 Phyllodes tumour Malignant mass 4 cm Benign (fat necrosis) Ditto Benign Suspicious
malignant
8. 37 Ductal carcinoma Malignant mass 1 cm Benign (fibro-adipose) Ditto Benign Suspicious
9. 49 Ductal carcinoma Malignant mass 4 cm Benign cytospin Ditto Malignant calcific Ditto
10. 57 Ductal carcinoma Malignant mass 5 cm Benign (fat necrosis) Inadequate Malignant opacity Ditto
11. 83 Ductal carcinoma Malignant mass 2 cm Benign (fibroadipose) Inadequate Malignant opacity Ditto
12. 72 Ductal carcinoma Suspicious mass 3 cm Benign (fat necrosis) Ditto Malignant stellate Ditto
lesion
13. 83 Papillary carcinoma in situ Malignant mass 3 cm Benign cytospin Papillary groups Malignant Ditto
14. 52 Carcinoma NOS Malignant mass 3 cm Benign (fat necrosis) Suspicious Malignant stellate Ditto
lesion
15. 32 Carcinoma NOS Malignant mass 4 cm Malignant Ditto Benign density Ditto
16. 35 Carcinoma NOS Suspicious mass 3 cm Malignant Ditto Fribrocystic changes Ditto
17. 44 Ductal carcinoma in situ Malignant mass 3 cm Malignant Ditto Normal Normal
NOS = not otherwise specified.
made in 426 (80,5%) patients, indeterminate diagnoses in a
further 96 (18,1 %) instances and the incorrect diagnosis of
benign disease in 7 (1,3%), :Tof which were revised to
'suspicious' on review.
Table IV. The mammographic and cytological diagnoses in 529




Benign 4 1 5 10
Indeterminate ° 23 41 64Malignant 3 72 380 455- - - -
Total 7 96 426 529
Overall, an accurate triple assessment (clinical, cytological
and mammographic) was made in 468 (66,4%) instances.
Indeterminate diagnoses were frequent: 223 (31,6%)
patients overall, 86 (48,9%) benign masses, 137 (25,9%)
malignant masses, 117 (16,6%) cytological instances and
141 (20%) mammographic instances. 80th cytological and
mammographic findings were incorrect in 4 (0,6%)
instances.
Discussion
In patients with suspicious breast masses, the safety in
proceeding to definitive cancer surgery on the results of
combined assessment alone - without recourse to excision
or core biopsy - relies on the specificity of the combination
(i.e. no erroneous diagnosis of malignancy with benign
lesions). We found our specificity to be complete, and no
patient would have had inappropriate surgery for benign
disease. We have thus abandoned open or core biopsy as a
routine method of pre-operative diagnosis in suspected
breast cancer. Others have evaluated triple assessment, and
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have also adopted this approach.1-6 Kreuzer and Boquoi'
reported that they were able to reach a decisive pre-
operative diagnosis with triple assessment in 40% of 602
cases, finding 1 false positive (duct papilloma) among 355
benign lesions. Hermansen et a/. 2 found no false positive
diagnoses among 115 lesions identified by triple assessment
as benign, but placed 42 of these patients in an
indeterminate ('suspect') group. Di Pietro et a/. 5 found no
false positive diagnoses in 346 benign masses. Others have
evaluated each component of triple assessment separately,
have emphasised the value of the cytological component
and found no false positive diagnoses.3.' Certain authors
have been disappointed with the mammographic
component, finding it of questionable value,' or that it did
not augment the clinical and cytological findings,' a view
which we cannot support on the basis of our data.
An inherent problem in any analysis of a triple assessment
is skewing of the data. The clinical component entails the
problems of the requisite investigation of most masses in
women over 30 years (with overdiagnosis of malignancy or
the suspicion thereof, and subsequent low clinical
sensitivity).
Unfortunately, a decisive combined assessment was only
made in two-thirds of cases; the balance of 32% were
indeterminate, and required either core or excision biopsy.
This problem was more frequently found in benign (49%)
than malignant disease (26%), and occurred despite our
immediate reporting of the cytology assessment (and the
possibility of repeating it), and the ability to have immediate
magnified mammographic views of areas of interest if
required. Others have found a significant number of
indeterminate diagnoses using combined assessment:
Kreuzer and Boquoi' had an overall indeterminate rate of
23% finding, as we did, that the problem occurred more
with the benign (50%) than the malignant (14%) masses.
Others have reported indeterminate combined assessment
rates of 35%,' 36%; 40%' and 41 %.'
The broad indeterminate band of diagnoses might be
refined and narrowed if a stratified approach were adopted,
rather than a dichotomous one (benign or malignant) or one
with three possibilities, including 'indeterminate', as we
used. The Southampton group suggested such an
approach:"'o they assessed each component of the
combined assessment on a 5-point scale: -2 (definitely
benign), -1 (probably benign), 0 (inconclusive), +1 (probably
malignant), +2 (definitely malignant). Patients with scores
between +4 and +6 of the triple assessment were treated
with definitive surgery. They were thus able to identify 95%
of cancers in a group of young women, where accurate
diagnosis can be very difficult. The Nashville group
proposed a stratified diagnostic approach to cytological
analysis: they categorised their reports into four (benign,
suspicious, probable and definite carcinoma), and found no
false positives in 62 patients in the 'definite' category, and
only 3 in 25 patients in the 'probable' category."
We therefore recommend that women with palpable
breast masses that are suspicious of malignancy undergo
combined assessment; surgery may be undertaken with
confidence and without recourse to core or excision biopsy
if there are clinical, cytological and mammographic features
of malignancy. In an environment where immediate
cytological and mammographic reporting are available,
these investigations may be repeated when inadequate, or
additional magnified mammographic views may be obtained
of suspicious areas during the same consultation. We
suggest that core biopsy be performed for discrete masses
under the following circumstances: (I) when the cytological
or mammographic features are indeterminate; (if) in patients
with inoperable disease, for histological characterisation;
and (iiJ) where the combined assessment is completely
negative in a patient over 30 years old.
REFERENCES
1. Kreuzer G, Boquoi E. Aspiration biopsy cytology, mammography and clinical
exploration: a modern set up in diagnosis of tumours of the breast. Acta Gyrol
1976; 20: 319-323.
2. Hermansen C, Poulsen HS, Jensen J, et al. Palpable breast tumours: triple
diagnosis and operative strategy. Results of a prospective stUdy. Acta Chir Scand
1984; 150: 625-628.
3. Dixon JM, Anderson TJ. Lamb J. Nixon SJ, Forrest APM. Fine needle aspiration
cytology, in relationship to clinical examination and mammography in the
diagnosis of a solid breast mass. Br J Surg 1984; 71: 593-596.
4. Smallwood J, Herbert A, Guyer P, Taylor I. Accuracy of aspiration cytology in the
diagnosis of breast disease. Br J Surg 1985; 72: 841 -843.
5. Di Pietro 5, Fariselli G, Bandieramonte G. et al. Diagnostic efficiency of the
clinical - radiological - cytological triad in solid breast lumps: results of a
second prospective study in 631 patients. Eur J Surg Oncol 1987; 13: 335-340.
6. Grobler SP, Du Toit RS. Brink C, Divall SP, Middlecote BD, Nel CJC. Pre-
operative evaluation of palpable breast tumours. S Afr Med J 1990; 28: 128·132.
7. Merion Thomas J, Fitzharris BM, Redding WH, et al. Clinical examination,
xeromammography, and fine needle aspiration cytology in diagnosis of breast
tumours. BMJ 1978; 2: 1139-1141.
8. Crone P, Hertz J, Nilsson T, et al. The predictive value of three diagnostic
procedures in the evaluation of palpable breast tumours. Ann Chir Gynaecol
1984; 73: 273-276.
9. Stone MD, Cady B. Techniques of lumpectomy and axillary dissecfion. Surg Clin
North Am 1990; 70: 885-899.
10. Ashley 5, Royle GT, Carder A, et al. Clinical, radiological and cytological
diagnosis of breast cancer in young women. Br J Surg 1989; 76: 835-837.
11. Casey TT, Rodgers WH, Baxter JW, Sawyers JL, Reynolds VH, Page DL.
Stratified diagnostic approach to fine needle aspiration of the breast. Am J Surg
1992; 163: 305-311.
Accepted 1 Sep 1993.
Volume 85 No. 2 February 1995 SAMJ
